Refresh

Marksans Pharma Ltd. - Research Center

524404 MARKSANS Group (A) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20 Mar ' 19
Income

Operating income

655.20 658.29 599.55 433.42 424.16
Expenses

Material consumed

394.45 377.59 337.91 243.03 236.34

Manufacturing expenses

14.24 11.27 10.90 8.95 8.22

Personnel expenses

56.09 60.46 54.64 48.51 46.33

Selling expenses

- - - - -

Adminstrative expenses

98.52 95.25 82.38 61.43 69.94

Expenses capitalised

- - - - -

Cost of sales

563.30 544.57 485.84 361.93 360.83

Operating profit

91.90 113.72 113.71 71.49 63.33

Other recurring income

60.48 42.25 31.16 0.17 7.93

Adjusted PBDIT

152.39 155.97 144.87 71.66 71.26

Financial expenses

3.61 3.80 5.34 7.29 6.56

Depreciation

16.74 17.66 15.19 11.64 8.69

Other write offs

- - - - -

Adjusted PBT

132.04 134.51 124.33 52.73 56.01

Tax charges

29.17 30.52 25.95 14.82 12.39

Adjusted PAT

102.87 103.99 98.38 37.90 43.62

Non recurring items

-0.59 0.05 -0.20 0.16 0.03

Other non cash adjustments

- - - - -

Reported net profit

102.28 104.03 98.19 38.07 43.65

Earnigs before appropriation

257.48 165.44 65.50 -24.67 -60.69

Equity dividend

10.17 10.23 4.09 2.47 2.05

Preference dividend

- - - - -

Dividend tax

- - - - -

Retained earnings

247.31 155.21 61.41 -27.14 -62.74
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com